Rocket Pharma (RCKT)
NASDAQ:RCKT
Want to see RCKT full AI Analyst Report?
RCKT Analyst Ratings
Moderate Buy
7 Buy
4 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RCKT Stock 12 Month Forecast
Average Price Target
$9.67
▲(147.23% Upside)
| Highest Price Target$16.00 | Average Price Target$9.67 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
LifeSci Capital
$9→$12
Buy
206.91%
Upside
Reiterated
04/16/26
Needham
―
Hold
―
Reiterated
04/15/26
J.P. Morgan
―
Sell
―
Reiterated
04/02/26
Bank of America Securities
$8→$9
Buy
130.18%
Upside
Reiterated
03/27/26
Chardan Capital
$11
Buy
181.33%
Upside
Reiterated
03/27/26
Goldman Sachs
$4.69→$3
Sell
-23.27%
Downside
Reiterated
03/27/26
Morgan Stanley
$5
Hold
27.88%
Upside
Reiterated
03/27/26
Leerink Partners
$9→$11
Hold
181.33%
Upside
Assigned
03/27/26
Wedbush
$4.69→$16
Buy
309.21%
Upside
Assigned
03/27/26
Cantor Fitzgerald
$8→$10
Buy
155.75%
Upside
Reiterated
02/27/26
TD Cowen
―
Hold
―
Initiated
02/26/26
William Blair
―
Buy
―
Reiterated
02/26/26
Evercore ISI
$5
Hold
27.88%
Upside
Reiterated
12/17/25
Jefferies
$2.5→$3
Hold
-23.27%
Downside
Reiterated
08/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
$9→$12
Buy
206.91%
Upside
Reiterated
04/16/26
Needham
―
Hold
―
Reiterated
04/15/26
J.P. Morgan
―
Sell
―
Reiterated
04/02/26
Bank of America Securities
$8→$9
Buy
130.18%
Upside
Reiterated
03/27/26
Chardan Capital
$11
Buy
181.33%
Upside
Reiterated
03/27/26
Goldman Sachs
$4.69→$3
Sell
-23.27%
Downside
Reiterated
03/27/26
Morgan Stanley
$5
Hold
27.88%
Upside
Reiterated
03/27/26
Leerink Partners
$9→$11
Hold
181.33%
Upside
Assigned
03/27/26
Wedbush
$4.69→$16
Buy
309.21%
Upside
Assigned
03/27/26
Cantor Fitzgerald
$8→$10
Buy
155.75%
Upside
Reiterated
02/27/26
TD Cowen
―
Hold
―
Initiated
02/26/26
William Blair
―
Buy
―
Reiterated
02/26/26
Evercore ISI
$5
Hold
27.88%
Upside
Reiterated
12/17/25
Jefferies
$2.5→$3
Hold
-23.27%
Downside
Reiterated
08/08/25
Best Analysts Covering Rocket Pharmaceuticals
3 Months
xxx
Success Rate
15/26 ratings generated profit
Average Return
+11.43%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.69% of your transactions generating a profit, with an average return of +11.43% per trade.
1 Year
Success Rate
19/33 ratings generated profit
Average Return
+9.35%
Copying Patrick Dolezal's trades and holding each position for 1 Year would result in 57.58% of your transactions generating a profit, with an average return of +9.35% per trade.
2 Years
xxx
Success Rate
11/33 ratings generated profit
Average Return
+13.82%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +13.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RCKT Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
8
6
4
10
10
Buy
2
1
1
1
1
Hold
6
3
4
6
6
Sell
1
1
0
2
3
Strong Sell
0
0
0
0
0
total
17
11
9
19
20
Each month's total comprises the sum of three months' worth of ratings.
RCKT Financial Forecast
RCKT Stock Forecast FAQ
What is RCKT’s average 12-month price target, according to analysts?
Based on analyst ratings, Rocket Pharma’s 12-month average price target is 9.67.
What is RCKT’s upside potential, based on the analysts’ average price target?
Rocket Pharma has 147.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RCKT a Buy, Sell or Hold?
Rocket Pharma has a consensus rating of Moderate Buy which is based on 7 buy ratings, 4 hold ratings and 2 sell ratings.
What is Rocket Pharma’s price target?
The average price target for Rocket Pharma is 9.67. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.00 ,the lowest forecast is $3.00. The average price target represents 147.23% Increase from the current price of $3.91.
The highest analyst price target is $16.00 ,the lowest forecast is $3.00. The average price target represents 147.23% Increase from the current price of $3.91.
What do analysts say about Rocket Pharma?
Rocket Pharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of RCKT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.